Curcumin and colon cancer: from preclinical to clinical studies
DOI:
https://doi.org/10.54097/hset.v54i.9751Keywords:
colon cancer; curcumin; cell apoptosis; in vitro studies; in vivo studies.Abstract
In the US, colon cancer has the third most mortality. Though new managements have reported upgraded prognosis, the five-year survival rates of patients with general or metastatic colon cancer are still unsatisfied at 64.7% and 20%, respectively. As a result, more innovative therapies or drugs with high efficacy should be developed. Curcumin, a natural chemical compound, is now in the spotlight of both preclinical and clinical trials on colon cancer. It not only exerts exceptional anti-cancer effects, but also anti-inflammatory and antiviral bio-activities. However, curcumin shows low bioavailability when orally administered. To resolve this issue, nanoparticles have been widely utilized. In this review, we precisely summarize the effects of curcumin on colon cancer in both preclinical and clinical studies. In vitro studies, curcumin could arrest cell cycle at the G2/M phase as well as part of the G1 phase, and induce cell apoptosis by binding to targeted molecules. Except for this, epigenetic alterations could also induce colon cancer. Both in vitro and in vivo studies have proved that curcumin could remarkably influence the prognosis. Moreover, genetically designed murine models which were orally administered with curcumin demonstrated satisfactory effects on colon cancer induced by different factors. More importantly, curcumin alone or as an adjuvant showed satisfactory results in numerous clinical trials. In conclusion, curcumin demonstrated outstanding anti-cancer activity against colon cancer.
Downloads
References
Colorectal cancer statistics: How common is colorectal cancer? Colorectal Cancer Statistics | How Common Is Colorectal Cancer? (n.d.). Retrieved March 18, 2023, from https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html
Colon cancer (colorectal cancer). Cleveland Clinic. (n.d.). Retrieved March 17, 2023, from https://my.clevelandclinic.org/health/diseases/14501-colorectal-colon-cancer
Fabregas, J. C., Ramnaraign, B., & George, T. J. (2022). Clinical updates for colon cancer care in 2022. Clinical Colorectal Cancer, 21(3), 198–203. https://doi.org/10.1016/j.clcc.2022.05.006
Pricci, M., Girardi, B., Giorgio, F., Losurdo, G., Ierardi, E., & Di Leo, A. (2020). Curcumin and colorectal cancer: From basic to clinical evidences. International Journal of Molecular Sciences, 21(7), 2364. https://doi.org/10.3390/ijms21072364
Ali, B. H., Marrif, H., Noureldayem, S. A., Bakheit, A. O., & Blunden, G. (2006). Some biological properties of curcumin: A Review. Natural Product Communications, 1(6). https://doi.org/10.1177/1934578x0600100613
Villegas, C., Perez, R., Sterner, O., González-Chavarría, I., & Paz, C. (2021). Curcuma as an adjuvant in colorectal cancer treatment. Life Sciences, 286, 120043. https://doi.org/10.1016/j.lfs.2021.120043
Giordano, & Tommonaro. (2019). Curcumin and cancer. Nutrients, 11(10), 2376. https://doi.org/10.3390/nu11102376
de, V. M. H. van, & Müller, B. (2017). Nanoscience and nanotechnology for human health. Wiley-VCH Verlag GmbH & Co. KGaA.
Selvam, C., Prabu, S. L., Jordan, B. C., Purushothaman, Y., Umamaheswari, A., Hosseini Zare, M. S., & Thilagavathi, R. (2019). Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment. Life Sciences, 239, 117032. https://doi.org/10.1016/j.lfs.2019.117032
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015). The multifaceted role of curcumin in cancer prevention and treatment. Molecules, 20(2), 2728–2769. https://doi.org/10.3390/molecules20022728
Dehzad, M. J., Ghalandari, H., Nouri, M., & Askarpour, M. (2023). Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A grade-assessed systematic review and dose–response meta-analysis of randomized controlled trials. Cytokine, 164, 156144. https://doi.org/10.1016/j.cyto.2023.156144
Li, Y., Wang, J., Liu, Y., Luo, X., Lei, W., & Xie, L. (2020). Antiviral and virucidal effects of curcumin on transmissible gastroenteritis virus in vitro. Journal of General Virology, 101(10), 1079–1084.
Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017). Curcumin inhibits zika and chikungunya virus infection by inhibiting cell binding. Antiviral Research, 142, 148–157. https://doi.org/10.1016/j.antiviral.2017.03.014
Balasubramanian, A., Pilankatta, R., Teramoto, T., Sajith, A. M., Nwulia, E., Kulkarni, A., & Padmanabhan, R. (2019). Inhibition of dengue virus by curcuminoids. Antiviral Research, 162, 71–78. https://doi.org/10.1016/j.antiviral.2018.12.002
Hesari, A. R., Ghasemi, F., Salarinia, R., Biglari, H., Tabar Molla Hassan, A., Abdoli, V., & Mirzaei, H. (2018). Effects of curcumin on NF‐ΚB, AP‐1, and Wnt/β‐catenin signaling pathway in hepatitis B virus infection. Journal of Cellular Biochemistry, 119(10), 7898–7904. https://doi.org/10.1002/jcb.26829
Villegas, C., Perez, R., Sterner, O., González-Chavarría, I., & Paz, C. (2021). Curcuma as an adjuvant in colorectal cancer treatment. Life Sciences, 286, 120043. https://doi.org/10.1016/j.lfs.2021.120043
Pricci, M., Girardi, B., Giorgio, F., Losurdo, G., Ierardi, E., & Di Leo, A. (2020). Curcumin and colorectal cancer: From basic to clinical evidences. International Journal of Molecular Sciences, 21(7), 2364. https://doi.org/10.3390/ijms21072364
Mosieniak, G., Adamowicz, M., Alster, O., Jaskowiak, H., Szczepankiewicz, A. A., Wilczynski, G. M., Ciechomska, I. A., & Sikora, E. (2012). Curcumin induces permanent growth arrest of human colon cancer cells: Link between senescence and autophagy. Mechanisms of Ageing and Development, 133(6), 444–455. https://doi.org/10.1016/j.mad.2012.05.004
Lim, T.-G., Lee, S.-Y., Huang, Z., Lim, D. Y., Chen, H., Jung, S. K., Bode, A. M., Lee, K. W., & Dong, Z. (2014). Curcumin suppresses proliferation of colon cancer cells by targeting CDK2. Cancer Prevention Research, 7(4), 466–474. https://doi.org/10.1158/1940-6207.capr-13-0387
Kim, K.-C., & Lee, C. H. (2010). Curcumin induces downregulation of E2F4 expression and apoptotic cell death in HCT116 human colon cancer cells; involvement of reactive oxygen species. The Korean Journal of Physiology and Pharmacology, 14(6), 391. https://doi.org/10.4196/kjpp.2010.14.6.391
Watson, J. L., Hill, R., Yaffe, P. B., Greenshields, A., Walsh, M., Lee, P. W., Giacomantonio, C. A., & Hoskin, D. W. (2010). Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Letters, 297(1), 1–8. https://doi.org/10.1016/j.canlet.2010.04.018
Song, G., Mao, Y. B., Cai, Q. F., Yao, L. M., Ouyang, G. L., & Bao, S. D. (2005). Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Brazilian Journal of Medical and Biological Research, 38(12), 1791–1798. https://doi.org/10.1590/s0100-879x2005001200007
Lee, Y.-K., Park, S. Y., Kim, Y.-M., & Park, O. J. (2009). Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Annals of the New York Academy of Sciences, 1171(1), 489–494. https://doi.org/10.1111/j.1749-6632.2009.04699.x
Collett, G. P., & Campbell, F. C. (2006). Overexpression of p65/RELA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis, 27(6), 1285–1291. https://doi.org/10.1093/carcin/bgi368
Narayan, S. (2003). Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting β-catenin-mediated transactivation and cell–cell adhesion pathways. Journal of Molecular Histology, 35(3), 301–307. https://doi.org/10.1023/b:hijo.0000032361.98815.bb
Link, A., Balaguer, F., Shen, Y., Lozano, J. J., Leung, H.-C. E., Boland, C. R., & Goel, A. (2013). Curcumin modulates DNA methylation in colorectal cancer cells. PLoS ONE, 8(2). https://doi.org/10.1371/journal.pone.0057709
Perkins, S., Verschoyle, R. D., Hill, K., Parveen, I., Threadgill, M. D., Sharma, R. A., Williams, M. L., Steward, W. P., & Gescher, A. J. (2002). Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 11(6), 535–540.
McFadden, R.-M. T., Larmonier, C. B., Shehab, K. W., Midura-Kiela, M., Ramalingam, R., Harrison, C. A., Besselsen, D. G., Chase, J. H., Caporaso, J. G., Jobin, C., Ghishan, F. K., & Kiela, P. R. (2015). The role of curcumin in modulating colonic microbiota during colitis and colon cancer prevention. Inflammatory Bowel Diseases, 21(11), 2483–2494. https://doi.org/10.1097/mib.0000000000000522
Guo, Y., Wu, R., Gaspar, J. M., Sargsyan, D., Su, Z.-Y., Zhang, C., Gao, L., Cheng, D., Li, W., Wang, C., Yin, R., Fang, M., Verzi, M. P., Hart, R. P., & Kong, A.-N. (2018). DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. Carcinogenesis, 39(5), 669–680. https://doi.org/10.1093/carcin/bgy043
Seiwert, N., Fahrer, J., Nagel, G., Frank, J., Behnam, D., & Kaina, B. (2020). Curcumin administered as micellar solution suppresses intestinal inflammation and colorectal carcinogenesis. Nutrition and Cancer, 73(4), 686–693. https://doi.org/10.1080/01635581.2020.1771384
He, Z. Y., Shi, C. B., Wen, H., Li, F. L., Wang, B. L., & Wang, J. (2011). Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer investigation, 29(3), 208–213. https://doi.org/10.3109/07357907.2010.550592
Cruz-Correa, M., Shoskes, D. A., Sanchez, P., Zhao, R., Hylind, L. M., Wexner, S. D., & Giardiello, F. M. (2006). Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4(8), 1035–1038. https://doi.org/10.1016/j.cgh.2006.03.020
Weng, W., & Goel, A. (2022). Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Seminars in Cancer Biology, 80, 73–86. https://doi.org/10.1016/j.semcancer.2020.02.011
James, M. I., Iwuji, C., Irving, G., Karmokar, A., Higgins, J. A., Griffin-Teal, N., Thomas, A., Greaves, P., Cai, H., Patel, S. R., Morgan, B., Dennison, A., Metcalfe, M., Garcea, G., Lloyd, D. M., Berry, D. P., Steward, W. P., Howells, L. M., & Brown, K. (2015). Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with Folfox chemotherapy. Cancer Letters, 364(2), 135–141. https://doi.org/10.1016/j.canlet.2015.05.005
Howells, L. M., Iwuji, C. O., Irving, G. R., Barber, S., Walter, H., Sidat, Z., Griffin-Teall, N., Singh, R., Foreman, N., Patel, S. R., Morgan, B., Steward, W. P., Gescher, A., Thomas, A. L., & Brown, K. (2019). Curcumin combined with Folfox Chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIA trial. The Journal of Nutrition, 149(7), 1133–1139. https://doi.org/10.1093/jn/nxz029
Park, J. (2010). Anti-carcinogenic properties of curcumin on colorectal cancer. World Journal of Gastrointestinal Oncology, 2(4), 169. https://doi.org/10.4251/wjgo.v2.i4.169
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
